30, 2019. The conclusions are as follow; Operating performance : 1. Revenue : The total revenue of the 2nd quarter of year 2019 was Baht 858.56 million representing a decrease 26.96% comparing to the

by 0.72 Million Baht or 27.08% the main cause is due to expand product sales in the Modern Trade. 2. Dividend income 6.04 Million Baht decrease from the same period last year by 4.84 Million Baht. This

. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 62.50%. These are caused by an increased in sales of good to customers in modern trade group, in addition to the economic condition and customer’s

/ (decrease) %change Revenues from sales and Service income 217.59 157.19 60.40 38.42% Other revenues 2.37 0.18 2.19 1,216.67% Total revenues 219.96 157.37 62.59 39.77% Cost of sales and Service income 109.51

decrease in numbers when compared to the revenue of Q3/2018. Though, the revenue figure of this period may seem a little less than the one before in Q3/2018. The slight decrease in numbers is due to the

3Q2016 and 3Q2017 were in amounts of Baht 155.79 million and Baht 127.59 million, respectively, which decreased by 18.0%. There are three main reasons for the decrease in revenue. Firstly, the southern

period ended December 31, 2018, resulted in decrease in net profit of Baht 16.49 million or 11.78% from the corresponding period of the previous year as the following details below: 1. Revenue from sales

March 2017 mainly from a decrease in 1) short term loans, long term loans and current portion of long term loans of THB 548mn, THB 444mn and THB 202mn, respectively, 2) trade and other payables of THB

sale revenue was not sufficient to support the Company’s expenses which effect to the company’s net loss for this period amount of 65.92 million Baht that represented decrease loss 566.45 million Baht or

December 2023. The decrease in liabilities was mainly due to: • Current Liabilities: increased by THB 11 million due to the increase in trade payables by THB 14 million, other payables and accrued expenses